Headline data from the national lung cancer audit
| 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|
| Data Completeness | |||||||||
| Number of cases | 10,920 | 16,922 | 20,639 | 25,757 | 30,158 | 30,329 | 31,429 | 31,003 | 30,508 |
| PS | 66% | 77% | 80% | 87% | 88% | 84% | 89% | 91% | 93% |
| Staging | 51% | 55% | 70% | 77% | 80% | 82% | 84% | 94% | 93% |
| Treatment | 66% | 72% | 79% | 82% | 89% | 89% | 91% | 91% | 92% |
| Process and Outcomes | |||||||||
| HCR | 68% | 66% | 65% | 66.7% | 69.5% | 76.5% | 73.8% | 75.5% | 75.1% |
| NSCLC NOS rate | - | 36% | 32% | 33.6% | 30% | 24% | 19% | 16% | 13% |
| Discussed at MDT? | 79% | 84.3% | 86.8% | 88.6% | 93.2% | 96.1% | 95.9% | 95.6% | 95.2% |
| Anti-cancer treatment? | 45% | 50% | 52% | 54% | 58.9% | 58.5% | 60.5% | 61.0% | 60.2% |
| Overall resection rate | 9% | 9.4% | 10.3% | 11.2% | 13.9% | 13.9% | 15.3% | 15.5% | 15.4% |
| NSCLC resection rate | 13.8% | 14.3% | 15.2% | 16% | 19% | 18.3% | 21% | 22% | 23% |
| SCLC chemotherapy rate | 57.7% | 61.7% | 64.5% | 63% | 66% | 65% | 68% | 68% | 70% |
| Seen by LCNS | - | - | - | 50.9% | 64.4% | 75.5% | 79.4% | 81.9% | 83.9% |
| LCNS at diagnosis | - | - | - | 28.5% | 41% | 51.9% | 58.7% | 61.2% | 65.3% |
HCR=histo-cytological confirmation rate; LCNS=lung cancer specialist nurse; NOS=not otherwise specified